World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
173
Citations
133687
World Ranking
767
National Ranking
468

Immunology

D-Index
172
Citations
131422
World Ranking
49
National Ranking
36

Medicine

D-Index
175
Citations
135688
World Ranking
426
National Ranking
255

Howard L. Weiner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Howard L. Weiner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 1,088 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Howard L. Weiner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Howard L. Weiner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 172 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

Howard L. Weiner is affiliated with Harvard University in the United States and has a prolific publication record in the field of medicine, primarily focusing on neurology and related subfields. Their work spans several interconnected disciplines including immunology, molecular biology, pathology and forensic medicine, and psychiatry and mental health.

They have contributed extensively to research topics such as multiple sclerosis, neuroinflammation, neurodegeneration, epilepsy, gut microbiota, peripheral neuropathies, tryptophan in brain disorders, and Alzheimer's disease research and treatments. The breadth of these topics reflects a deep engagement with neurological disorders and their underlying mechanisms.

Notable recent publications by Howard L. Weiner include:

  • Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations, 2021, Pediatric Neurology
  • Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course, 2022, Cell
  • Blood neurofilament light: a critical review of its application to neurologic disease, 2020, Annals of Clinical and Translational Neurology
  • Gut Microbiome in Progressive Multiple Sclerosis, 2021, Annals of Neurology
  • Locus for severity implicates CNS resilience in progression of multiple sclerosis, 2023, Nature

Howard L. Weiner has published frequently in several scientific journals, with the most frequent venues including:

  • Neurology (31 publications)
  • Journal of Neurosurgery Pediatrics (14 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (12 publications)
  • Epilepsia (9 publications)
  • Multiple Sclerosis and Related Disorders (9 publications)

Collaboration has been a significant part of their academic activity, working closely with co-authors such as:

  • Tanuja Chitnis (92 joint publications)
  • Brian C. Healy (55 joint publications)
  • Bonnie I. Glanz (43 joint publications)
  • Rohit Bakshi (34 joint publications)
  • Laura M. Cox (31 joint publications)

The main fields of study for Howard L. Weiner focus on the medical sciences with a strong specialization in neurology and related life science fields. Their research emphasizes understanding neurological conditions with an interdisciplinary approach involving immunological and molecular biological perspectives.

Best Publications

  • Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

    Estelle Bettelli;Yijun Carrier;Wenda Gao;Thomas Korn

  • The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases

    Susanne Krasemann;Susanne Krasemann;Charlotte Madore;Ron Cialic;Caroline Baufeld

  • Identification of a unique TGF-β–dependent molecular and functional signature in microglia

    Oleg Butovsky;Mark P Jedrychowski;Craig S Moore;Ron Cialic

  • Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

    Youhai Chen;Vijay K. Kuchroo;Jun-ichi Inobe;David A. Hafler

  • Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

    Vissia Viglietta;Clare Baecher-Allan;Howard L. Weiner;David A. Hafler

  • B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy

    Vijay K Kuchroo;Mercy Prabhu Das;Julia A Brown;Ann M Ranger

  • Control of T reg and T H 17 cell differentiation by the aryl hydrocarbon receptor

    Francisco J. Quintana;Alexandre S. Basso;Antonio H. Iglesias;Thomas Korn

  • Alterations of the human gut microbiome in multiple sclerosis

    Sushrut Jangi;Roopali Gandhi;Laura M. Cox;Ning Li

  • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

    Jeffrey A. Cohen;Alasdair J. Coles;Douglas L. Arnold;Christian Confavreux

  • Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: A randomised controlled phase 3 trial

    Alasdair J. Coles;Cary L. Twyman;Douglas L. Arnold;Jeffrey A. Cohen

  • Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

    Howard L. Weiner

  • Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens

    H. L. Weiner;A. Friedman;A. Miller;S. J. Khoury

  • Oral tolerance: immune mechanisms and treatment of autoimmune diseases

    Howard L. Weiner

  • T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

    Kohei Ota;Makoto Matsui;Edgar L. Milford;Glenn A. Mackin

  • Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

    Ariel Miller;Ofer Lider;Anita B. Roberts;Michael B. Sporn

  • CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions

    Konstantin E. Balashov;James B. Rottman;Howard L. Weiner;Wayne W. Hancock

  • Microglial signatures and their role in health and disease

    Oleg Butovsky;Howard L. Weiner

  • Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

    S J Khoury;W W Hancock;H L Weiner

  • Multiple Sclerosis: Mechanisms and Immunotherapy

    Clare Baecher-Allan;Belinda J. Kaskow;Howard L. Weiner

  • Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

    Hauser Sl;Dawson Dm;Lehrich;Beal Mf

  • Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

    Howard L Weiner

  • Erratum: Identification of a unique TGF-β-dependent molecular and functional signature in microglia (Nature Neuroscience (2014) 17 (131-143))

    Oleg Butovsky;Mark P. Jedrychowski;Craig S. Moore;Ron Cialic

Frequent Co-Authors

David A. Hafler
David A. Hafler Yale University
Samia J. Khoury
Samia J. Khoury American University of Beirut
Tanuja Chitnis
Tanuja Chitnis Harvard University
Rohit Bakshi
Rohit Bakshi Brigham and Women's Hospital
Francisco J. Quintana
Francisco J. Quintana Harvard Medical School
Charles R.G. Guttmann
Charles R.G. Guttmann Brigham and Women's Hospital
Stephen L. Hauser
Stephen L. Hauser University of California, San Francisco
Vijay K. Kuchroo
Vijay K. Kuchroo Harvard University
Philip L. De Jager
Philip L. De Jager Columbia University
Orrin Devinsky
Orrin Devinsky New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare and research careers, often complementing advanced nursing roles. For those interested in clinical practice, exploring pathways such as the fnp to acute care certification can enhance specialization in patient care within acute settings.

Nursing professionals looking to fast-track their education may consider an accelerated fnp program, which offers intensive training to become a Family Nurse Practitioner. These programs are ideal for individuals aiming to expand their role in primary health care swiftly.

For those beginning their healthcare journey without a nursing background, some of the best online bsn programs for non nurses provide comprehensive, flexible education pathways. These programs make it possible to enter the nursing field while gaining foundational knowledge pertinent to immunology and patient care.

Additionally, if you are seeking easier admission routes, the easiest absn to get into can be a practical choice. These accelerated BSN programs enable quicker transition into nursing roles, which can be particularly beneficial for students leveraging immunology expertise in clinical settings.

Best Scientists Citing Howard L. Weiner

Trending Scientists

Recently Published Articles